- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Pre-market Movers: Baosheng Media, Sharps Technology, New Century Logistics, NewGenIvf Group, Bon Natural Life | 232 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green Baosheng Media Group Holdings Limited (BAOS) is... ► Artikel lesen | |
| Mo | NewGenIvf Plans To Invest $30 Mln In Solana | 2 | RTTNews | ||
| Mo | NewGenIvf to invest $30M in Solana staking; shares up | 3 | Seeking Alpha | ||
| Mo | NewGenIVF Group Limited: NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking | 155 | GlobeNewswire (Europe) | BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| Mo | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 20.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 01.05. | NewGenIvf kündigt Aktienzusammenlegung im Verhältnis 1:10 an | 3 | Investing.com Deutsch | ||
| 01.05. | NewGenIvf announces 1-for-10 reverse stock split | 1 | Investing.com | ||
| 01.05. | NewGenIVF Group Limited: NewGenIVF Announces Reverse Stock Split | 95 | GlobeNewswire (Europe) | BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
| 01.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 29.04. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 22.04. | NewGenIVF Group Limited: NewGen Filed 2024 Annual Report on Form 20-F | 2 | GlobeNewswire (USA) | ||
| 22.04. | NewGenIvf Group Ltd - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 11.04. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.04. | NewGenIvf Stock Jumps 7% On Strategic Funding News | 2 | RTTNews | ||
| 03.04. | What's Going On With NewGenIvf Shares Thursday? | 1 | Benzinga.com | ||
| 03.04. | NewGenIVF Group Limited: NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth | 4 | GlobeNewswire (USA) | ||
| 03.04. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 31.03. | Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet | 2 | Benzinga.com |
Seite:
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,108 | -0,92 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,750 | +0,27 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,779 | -2,19 % | PA GOODDOCTOR (01833): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | ||
| MOUNTAIN VALLEY MD | 0,019 | +27,40 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,256 | 0,00 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| VERU | 0,558 | -2,28 % | Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave | ||
| CYTOSORBENTS | 0,899 | +1,58 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 5,240 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,570 | 0,00 % | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., May 15, 2025 /PRNewswire/... ► Artikel lesen | |
| EKSO BIONICS | 3,757 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS03485P3001 Anglo American PLC 30.05.2025 US03485P4090 Anglo American PLC 02.06.2025 Tausch 10:8,807339US03815U5083 Applied... ► Artikel lesen | |
| IMUNON | 1,450 | -3,33 % | IMNN-001 shows promise in ovarian cancer treatment | ||
| BEYOND AIR | 0,167 | +11,33 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| NOVACYT | 0,569 | +0,18 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights | ||
| AROVELLA THERAPEUTICS | 0,040 | +1,28 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
Das Unternehmen NEWGENIVF GROUP LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,010 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEWGENIVF GROUP LIMITED finden Sie auf Wallstreet Online.